Dexcom (Nasdaq:DXCM) announced today in an SEC filing that former CEO Kevin Sayer has returned from his leave of absence.

(NYSE:SENS) posted mixed fourth-quarter results compared to Wall Street forecasts alongside a major pipeline announcement.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it intends to offer $200 million in convertible senior notes, due in ...

Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost today on fourth-quarter results that came in ahead of the consensus ...

Sequel Med Tech and (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration.

Medtronic said today that the separation of its MiniMed Diabetes unit remains on track as it advances the MiniMed Flex system ...

Leach succeeds Abbott EVP of Diabetes Care, Chris Scoggins, in the position. Eric Benjamin, Insulet’s EVP and COO, will serve as the vice chair for the medical device industry association’s Diabetes ...

Insulet stock is up on fourth-quarter results ahead of consensus, with company leaders talking about talent, technology, and ...

In an amendment to an SEC filing, Medtronic's Diabetes unit, MiniMed, today priced its planned initial public offering (IPO).

Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a $25 million Standby Equity Purchase Agreement (SEPA).

Dexcom (Nasdaq:DXCM) announced that it appointed Rick Osterloh to its board of directors, effective Feb. 26, 2026.